Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-358469
Filing Date
2013-09-05
Accepted
2013-09-05 16:57:55
Documents
4
Period of Report
2013-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO.1 d594155d8ka.htm 8-K/A 15780
2 EX-10.12 d594155dex1012.htm EX-10.12 163785
3 GRAPHIC g594155g19s44.jpg GRAPHIC 238146
4 GRAPHIC g594155g95b41.jpg GRAPHIC 41295
  Complete submission text file 0001193125-13-358469.txt   566074
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-178230 | Film No.: 131080910
SIC: 2834 Pharmaceutical Preparations